Ferroptosis: Emerging Roles in Lung Cancer and Potential Implications in Biological Compounds

Overview

Journal Front Pharmacol

Date 2024 May 24

PMID 38783959

Authors

Qiuran Liang

Yuehui Wang

Yili Li

Jinyan Wang

Chuanbo Liu

Yicong Li

Affiliations

Soon will be listed here.

Abstract

Lung cancer has high metastasis and drug resistance. The prognosis of lung cancer patients is poor and the patients' survival chances are easily neglected. Ferroptosis is a programmed cell death proposed in 2012, which differs from apoptosis, necrosis and autophagy. Ferroptosis is a novel type of regulated cell death which is driven by iron-dependent lipid peroxidation and subsequent plasma membrane ruptures. It has broad prospects in the field of tumor disease treatment. At present, multiple studies have shown that biological compounds can induce ferroptosis in lung cancer cells, which exhibits significant anti-cancer effects, and they have the advantages in high safety, minimal side effects, and less possibility to drug resistance. In this review, we summarize the biological compounds used for the treatment of lung cancer by focusing on ferroptosis and its mechanism. In addition, we systematically review the current research status of combining nanotechnology with biological compounds for tumor treatment, shed new light for targeting ferroptosis pathways and applying biological compounds-based therapies.

References

Schmitt A, Xu W, Bucher P, Grimm M, Konantz M, Horn H . Dimethyl fumarate induces ferroptosis and impairs NF-κB/STAT3 signaling in DLBCL. Blood. 2021; 138(10):871-884. DOI: 10.1182/blood.2020009404. View

Zhang C, Liu X, Jin S, Chen Y, Guo R . Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022; 21(1):47. PMC: 8840702. DOI: 10.1186/s12943-022-01530-y. View

Fu F, Wang W, Wu L, Wang W, Huang Z, Huang Y . Inhalable Biomineralized Liposomes for Cyclic Ca-Burst-Centered Endoplasmic Reticulum Stress Enhanced Lung Cancer Ferroptosis Therapy. ACS Nano. 2023; 17(6):5486-5502. DOI: 10.1021/acsnano.2c10830. View

Zhai F, Liang Q, Wu Y, Liu J, Liu J . Red ginseng polysaccharide exhibits anticancer activity through GPX4 downregulation-induced ferroptosis. Pharm Biol. 2022; 60(1):909-914. PMC: 9116236. DOI: 10.1080/13880209.2022.2066139. View

Liu X, Peng X, Cen S, Yang C, Ma Z, Shi X . Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis. Front Pharmacol. 2023; 14:1129662. PMC: 9992170. DOI: 10.3389/fphar.2023.1129662. View

Li L, Peng X, Yu T, Xu H, Han N, Yang X . Dihydroartemisinin remodels macrophage into an M1 phenotype ferroptosis-mediated DNA damage. Front Pharmacol. 2022; 13:949835. PMC: 9403990. DOI: 10.3389/fphar.2022.949835. View

Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P . BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018; 20(10):1181-1192. PMC: 6170713. DOI: 10.1038/s41556-018-0178-0. View

Chen T, Chuang J, Ko C, Kao T, Yang P, Yu C . AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis. Redox Biol. 2020; 30:101413. PMC: 6940696. DOI: 10.1016/j.redox.2019.101413. View

Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K . Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell. 2018; 172(3):409-422.e21. DOI: 10.1016/j.cell.2017.11.048. View

10.

Lu X, Wang C, Zhao M, Wu J, Niu Z, Zhang X . Improving the bioavailability and bioactivity of garlic bioactive compounds nanotechnology. Crit Rev Food Sci Nutr. 2021; 62(30):8467-8496. DOI: 10.1080/10408398.2021.1929058. View

11.

Feng W, Shi W, Cui Y, Xu J, Liu S, Gao H . Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination. Theranostics. 2023; 13(15):5266-5289. PMC: 10614674. DOI: 10.7150/thno.81650. View

12.

Zhang X, Ding Y, Zhang Z, Ma Y, Sun X, Wang L . Construction of Ferrocene-Containing Membrane-Bound Nanofibers for the Redox Control of Cancer Cell Death and Cancer Therapy. Nano Lett. 2023; 23(16):7665-7674. DOI: 10.1021/acs.nanolett.3c02362. View

13.

Golbashirzadeh M, Heidari H, Talebi M, Khosroushahi A . Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line. Adv Pharm Bull. 2023; 13(1):176-187. PMC: 9871276. DOI: 10.34172/apb.2023.019. View

14.

Zhou J, Zhang L, Yan J, Hou A, Sui W, Sun M . Curcumin Induces Ferroptosis in A549 CD133 Cells through the GSH-GPX4 and FSP1-CoQ10-NAPH Pathways. Discov Med. 2023; 35(176):251-263. DOI: 10.24976/Discov.Med.202335176.26. View

15.

Shan X, Li J, Liu J, Feng B, Zhang T, Liu Q . Targeting ferroptosis by poly(acrylic) acid coated MnO nanoparticles alleviates acute liver injury. Nat Commun. 2023; 14(1):7598. PMC: 10663555. DOI: 10.1038/s41467-023-43308-w. View

16.

Liu X, Zhang Y, Gao H, Hou Y, Lu J, Feng Y . Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells. Biochem Pharmacol. 2019; 171:113684. DOI: 10.1016/j.bcp.2019.113684. View

17.

Li B, Chen X, Qiu W, Zhao R, Duan J, Zhang S . Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy. Adv Sci (Weinh). 2022; 9(17):e2105451. PMC: 9189685. DOI: 10.1002/advs.202105451. View

18.

Conrad M, Pratt D . The chemical basis of ferroptosis. Nat Chem Biol. 2019; 15(12):1137-1147. DOI: 10.1038/s41589-019-0408-1. View

19.

Doll S, Porto Freitas F, Shah R, Aldrovandi M, Costa Da Silva M, Ingold I . FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019; 575(7784):693-698. DOI: 10.1038/s41586-019-1707-0. View

20.

Lai X, Shi Y, Zhou M . Dihydroartemisinin enhances gefitinib cytotoxicity against lung adenocarcinoma cells by inducing ROS-dependent apoptosis and ferroptosis. Kaohsiung J Med Sci. 2023; 39(7):699-709. DOI: 10.1002/kjm2.12684. View